Four operating sectorsPharmaceuticals, Specialties and Advanced Materials contribute together to more than 80% of the overall Solvay group results:
Pharmaceuticals 25%, Specialties 20 %, Advanced Materials 35 %
1999 figures
Four operating sectors organized into Strategic Business Units (SBUs)
Sales: EUR 1.35 billion (+16%)
EBIT: EUR 157 million (+16%)
|
Pharmaceuticals SBU |
Market position |
|||
| Four therapeutic areas | Main products |
Europe |
USA |
World |
|
Gastroenterology |
Gastrointestinal enzymes Laxatives Antispasmodics |
1 1 1 |
2 – – |
1 2 1 |
|
Hormone replacement therapy (HRT) |
Menoposal |
4 |
2 |
3 |
|
Psychiatry |
Antidepressants Vertigo (M�ni�re’s syndrome) |
12 1 |
8 – |
10 1 |
A range of fast growing pharmaceutical products resulting from a combination of internal growth supplemented by acquisitions (of products and companies) and a very significant increase in the number of medical representatives in the USA and Japan.
Sales:EUR 2.40 billion (-1%)
EBIT:EUR 212 million (+9%)
|
SBU |
Market position |
||
Main products |
Europe |
World |
|
|
Soda ash and derivatives |
Soda ash |
1 |
1 |
|
Hydrogen peroxide |
H2O2 |
1 |
1 |
|
Detergent |
Persalts |
1 |
1 |
|
Fluorinated products |
– |
4 |
|
|
Barium-Strontium |
Ba-Sr carbonates |
1 |
1 |
|
Chlor Chemicals |
NaOH (caustic soda) |
1 |
3 |
|
Salt |
NaCl |
1 |
4 |
|
Fillers |
SOCAL® |
– | – |
|
Caprolactones |
CAPA® |
– | – |
A well diversified portfolio:
Specialties, growing very strongly:
- Fluorinated products
- Fillers
- Caprolactones
- Ultra-pure hydrogen peroxide, and new applications being developed
High-volume products in which the Group has competitive advantages:
- Soda ash
- Hydrogen peroxide
- Barium-Strontium
- Caustic soda
Sales: EUR 2.62 billion (+8%)
EBIT: EUR 200 million (-2%)
|
SBU |
Market position |
||
Main products |
Europe |
World |
|
|
Polyolefins |
HD-PE PP |
4 6 |
3 10 |
|
Vinyls |
PVC |
2 |
4 |
|
PVC compounds |
BENVIC® |
– | – |
|
Specialty polymers |
SOLEF®, IXEF®, PRIMEF® |
– | – |
Sales: EUR 1.50 billion (+4%)
EBIT: EUR 83 million (+11%)
|
SBU |
Market position |
||
Main products |
Europe |
World |
|
|
Automotive |
HD-PE fuel tanks |
3 |
1 |
|
Industrial foils |
Waterproofing sheets
Medical supply (blood/ dialysis applications) |
1 – |
– 1 |
|
Pipes |
|
2 |
– |
|
Decoration |
Plastic tablecloths Self-adhesives |
1 1 |
3 2 |
A range of advanced materials and polymer specialties where the Group has a competitive cost structure and processing expertise as a result of its involvement in the most dynamic end-users markets: automotive, medical applications, pipes, engineering and construction.
Average contribution to Group EBIT (% of total)
| Commodities | 20% |
| Pharmaceuticals | 25% |
| Specialties | 20% |
| Advanced materials | 35% |
| Pharmaceuticals and other non-commodities | 80% |